Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Portelance

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Canadian Journal of Microbiology|October 1, 1975
Factors affecting the immunizing activity of ribosomal fractions isolated from Mycobacterium tuberculosis var. bovis strain BCGV Portelance, R Brasseur, R P Boulanger
Infection and Immunity|March 1, 1979
Protection of cotton rats against experimental Echinococcus multilocularis infections with BCG cell wallsJ M Reuben, C E Tanner, V Portelance
Journal of Medical Microbiology|July 1, 1988
Site of action of a gonococcal growth inhibitor produced by Staphylococcus haemolyticusM Frenette, R Beaudet, J G Bisaillon, et al.
Experimental Biology|January 1, 1985
In vitro inhibition of Neisseria gonorrhoeae growth by a urogenital strain of Streptococcus faecalisD Dubreuil, J G Bisaillon, R Beaudet, et al.
Journal of General Microbiology|February 1, 1971
Classification of vitamin K-deficient mutants of Staphylococcus aureusA Săsărman, M Surdeanu, V Portelance, et al.
Infection and Immunity|November 1, 1984
Chemical and biological characterization of a gonococcal growth inhibitor produced by Staphylococcus haemolyticus isolated from urogenital floraM Frenette, R Beaudet, J G Bisaillon, et al.
Canadian Journal of Microbiology|September 1, 1982
Evaluation of the immunogenicity of a CaCl2 extract from Neisseria meningitidis group YJ G Bisaillon, G McSween, V Portelance, et al.
Microbios|January 1, 1989
A potential polyvalent Neisseria meningitidis vaccine based on a mixture of CaCl2 cell extracts from groups A, B and YJ G Bisaillon, G McSween, V Portelance, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Canadian Journal of Microbiology|October 1, 1975
Factors affecting the immunizing activity of ribosomal fractions isolated from Mycobacterium tuberculosis var. bovis strain BCGV Portelance, R Brasseur, R P Boulanger
Infection and Immunity|March 1, 1979
Protection of cotton rats against experimental Echinococcus multilocularis infections with BCG cell wallsJ M Reuben, C E Tanner, V Portelance
Journal of Medical Microbiology|July 1, 1988
Site of action of a gonococcal growth inhibitor produced by Staphylococcus haemolyticusM Frenette, R Beaudet, J G Bisaillon, et al.
Experimental Biology|January 1, 1985
In vitro inhibition of Neisseria gonorrhoeae growth by a urogenital strain of Streptococcus faecalisD Dubreuil, J G Bisaillon, R Beaudet, et al.
Journal of General Microbiology|February 1, 1971
Classification of vitamin K-deficient mutants of Staphylococcus aureusA Săsărman, M Surdeanu, V Portelance, et al.
Infection and Immunity|November 1, 1984
Chemical and biological characterization of a gonococcal growth inhibitor produced by Staphylococcus haemolyticus isolated from urogenital floraM Frenette, R Beaudet, J G Bisaillon, et al.
Canadian Journal of Microbiology|September 1, 1982
Evaluation of the immunogenicity of a CaCl2 extract from Neisseria meningitidis group YJ G Bisaillon, G McSween, V Portelance, et al.
Microbios|January 1, 1989
A potential polyvalent Neisseria meningitidis vaccine based on a mixture of CaCl2 cell extracts from groups A, B and YJ G Bisaillon, G McSween, V Portelance, et al.
Pageof 2